News

Date

We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.

Date

A Parkinson's UK-funded study, inspired by a woman's ability to smell the condition, has resulted in the discovery of 10 molecules which could lead to the first diagnostic test for Parkinson's.